Results 31 to 40 of about 2,368,811 (205)

Supra and subgingival application of antiseptics or antibiotics during periodontal therapy

Periodontology 2000, EarlyView., 2023
Abstract Periodontal diseases (gingivitis and periodontitis) are characterized by inflammatory processes which arise as a result of disruption of the balance in the oral ecosystem. According to the current S3 level clinical practice guidelines, therapy of patients with periodontitis involves a stepwise approach that includes the control of the patient ...
Elena Figuero, Jorge Serrano, Nicole Birgit Arweiler, Thorsten Mathias Auschill, Ali Gürkan, Gülnur Emingil   +5 more
wiley   +1 more source

Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies [PDF]

Antimicrobial Agents and Chemotherapy, 2017
ABSTRACT Mycobacterium abscessus is an emerging pathogen against which clarithromycin is the main drug used. Clinical failures are commonly observed and were first attributed to acquired mutations in rrl encoding 23S rRNA but were then attributed to the intrinsic production of the ...
Mougari, Faiza, Bouziane, Feriel, Crockett, Flora, Nessar, Rachid, Chau, Françoise, Veziris, Nicolas, Sapriel, Guillaume, Raskine, Laurent, Cambau, Emmanuelle   +8 more
openaire   +2 more sources

Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection [PDF]

, 1998
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection.
Miehlke, Stephan, Bolle, Karl-Heinz, Lehn, Norbert, Höchter, Wilhelm, Klann, Hermann, Krämer, Walter, Simon, Thomas, Stolte, Manfred, Meining, Alexander, Sommer, Albrecht, Bayerdörffer, Ekkehard, Weingart, Josef   +11 more
core   +1 more source

A Mechanism of Clarithromycin Resistance in Helicobacter pylori

Journal of the Japanese Association for Infectious Diseases, 1998
The aim of this study was to elucidate the mechanism of clarithromycin (CAM) resistance in laboratory strains and clinical isolates of Helicobacter pylori. The CAM resistance in laboratory strains was induced in vitro by CAM exposure. The majority of CAM-resistant strains were highly resistant to CAM (MICs > 100 micrograms/ml).
T, Saika, I, Kobayashi, T, Fujioka, M, Nasu, R, Okamoto, M, Inoue   +5 more
openaire   +3 more sources

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo [PDF]

Journal of Antimicrobial Chemotherapy, 2007
Recently, there has been a decrease in the eradication rate of Helicobacter pylori due to the increase in antibiotic resistance of this bacterium. Plaunotol, a cytoprotective anti-ulcer agent, exhibits antibacterial activity against H. pylori. The purpose of the present study was to investigate the effect of plaunotol in combination with clarithromycin
Makoto, Sasaki, Tsutomu, Mizoshita, Takashi, Mizushima, Harumi, Inoue, Takeshi, Kamiya, Hiromi, Kataoka, Naotaka, Ogaswara, Tsuneya, Wada, Eiji, Kubota, Yoshinori, Mori, Takaya, Shimura, Hirokazu, Hirata, Kenji, Ando, Yasuyuki, Okamoto, Hirotaka, Ohara, Haruhisa, Nakao, Takashi, Joh   +16 more
openaire   +2 more sources

Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole–amoxicillin–clarithromycin therapy [PDF]

Alimentary Pharmacology & Therapeutics, 2001
Background: Helicobacter pylori resistance to clarithromycin is relatively frequent in France and is assumed to be the main cause of failure of the proton pump inhibitor–amoxicillin–clarithromycin (proton pump inhibitor–AC) therapy, which is the first‐line regimen in France.Aim:To determine the respective effects of clarithromycin primary and secondary
J, Tankovic, D, Lamarque, C, Lascols, C J, Soussy, J C, Delchier   +4 more
openaire   +2 more sources

Assessment of antimycobacterial activities of pure compounds extracted from Thai medicinal plants against clarithromycin-resistant Mycobacterium abscessus [PDF]

PeerJ, 2021
Background Infection with Mycobacterium abscessus is usually chronic and is associated with clarithromycin resistance. Increasing drug resistance is a major public-health problem and has led to the search for new antimycobacterial agents.
Auttawit Sirichoat, Irin Kham-ngam, Orawee Kaewprasert, Pimjai Ananta, Awat Wisetsai, Ratsami Lekphrom, Kiatichai Faksri   +6 more
doaj   +2 more sources

Clarithromycin-Resistant Mycobacterium avium Is Still Susceptible to Treatment with Clarithromycin and Is Virulent in Mice [PDF]

Antimicrobial Agents and Chemotherapy, 2000
ABSTRACT Resistance to clarithromycin in breakthrough Mycobacterium avium complex (MAC) isolates typically occurs 3 to 4 months after the initiation of monotherapy in bacteremic AIDS patients. It has been suggested that continuation of clarithromycin therapy still results in clinical and microbiological ...
L E, Bermudez, K, Nash, M, Petrofsky, L S, Young, C B, Inderlied   +4 more
openaire   +2 more sources

Clarithromycin-resistant Helicobacter pylori in Recife, Brazil, directly identified from gastric biopsies by polymerase chain reaction

Arquivos de Gastroenterologia, 2010
CONTEXT: Clarithromycin is the most effective drug used in the eradication of infection by Helicobacter pylori. Due to worldwide increase in resistance, pre-treatment susceptibility testing for clarithromycin is recommended.
Ana Kelly Lins, Roberto A Lima, Marcelo Magalhães   +2 more
doaj   +1 more source